Monthly: Fate Therapeutics (FATE: $2.51) shares post worst month in seven months

Press/Media

Period	1 Sep 2023

Media coverage

Title	Monthly: Fate Therapeutics (FATE: $2.51) shares post worst month in seven months
Media name/outlet	Global Round Up - Bullish & Bearish Signals
Country/Territory	United States
Date	1/09/23
URL	metabase.moreover.com/noarticleurl?type=psh&lni=692T-V141-DXKH-N31R-00000-00
Persons	Jared Scott